Fundsmith Equity R AccRegister to Unlock Ratings |
Performance History | 31/12/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 17.7 | 21.5 | -14.2 | 11.8 | 8.3 | |
+/-Cat | -6.0 | 6.9 | 3.8 | -4.2 | -6.9 | |
+/-B’mrk | - | 3.4 | 4.7 | -10.5 | -15.6 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 20/01/2025 | GBP 6.82 | |
Day Change | -0.17% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
IA (formerly IMA) Sector | Global | |
ISIN | GB00B4LPDJ14 | |
Fund Size (Mil) 29/11/2024 | GBP 23272.21 | |
Share Class Size (Mil) 20/01/2025 | GBP 599.26 | |
Max Initial Charge | - | |
Ongoing Charge 09/04/2024 | 1.54% |
Morningstar Research |
Analyst Report | 22/03/2024 Daniel Haydon, Analyst Morningstar, Inc |
The structured and methodical investment process overseen by a long-standing manager are among Fundsmith Equity's many strengths. The Morningstar Analyst Rating of Gold for most share classes, including the clean I share class, is retained. The... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 24 |
Process | 25 |
Performance | |
Price |
Investment Objective: Fundsmith Equity R Acc |
The investment objective of the Fund is to achieve long term growth (over 5 years) in value. The Fund will invest in equities on a global basis. The Fund's approach is to be a long-term investor in its chosen stocks. It will not adopt short-term trading strategies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Terry Smith 01/11/2010 | ||
Inception Date 01/11/2010 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Not Benchmarked | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fundsmith Equity R Acc | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 9.24 |
Microsoft Corp | Technology | 8.65 |
Meta Platforms Inc Class A | Communication Services | 7.82 |
L'Oreal SA | Consumer Defensive | 5.98 |
Stryker Corp | Healthcare | 5.66 |
Increase Decrease New since last portfolio | ||
Fundsmith Equity R Acc |